Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis
Vet. Res., 36 5-6 (2005) 827-838
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Unleashing the role of potential adjuvants in leishmaniasis
Isha Saini, Jyoti Joshi and Sukhbir KaurInternational Journal of Pharmaceutics 669 125077 (2025)
https://doi.org/10.1016/j.ijpharm.2024.125077
(2024)
https://doi.org/10.5772/intechopen.110569
Live attenuated Leishmania infantum centrin deleted mutant (LiCen) as a novel vaccine candidate: A field study on safety, immunogenicity, and efficacy against canine leishmaniasis
Zabihollah Zarei, Mehdi Mohebali, Hesam Dehghani, Ali Khamesipour, Jalil Tavakkol-Afshari, Behnaz Akhoundi, Mohammad Javad Abbaszadeh-Afshar, Zahra Alizadeh, Seyed Ebrahim Eskandari, Abdolhossein Dalimi Asl and Gholam Reza RazmiComparative Immunology, Microbiology and Infectious Diseases 97 101984 (2023)
https://doi.org/10.1016/j.cimid.2023.101984
Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges
Eduardo A. F. Coelho and Myron ChristodoulidesVaccines for Neglected Pathogens: Strategies, Achievements and Challenges 281 (2023)
https://doi.org/10.1007/978-3-031-24355-4_13
Deletion of MIF gene from live attenuated LdCen−/− parasites enhances protective CD4+ T cell immunity
Jacqueline Araújo Fiuza, Sreenivas Gannavaram, Soraya Torres Gaze, et al.Scientific Reports 13 (1) (2023)
https://doi.org/10.1038/s41598-023-34333-2
Live attenuated Leishmania major p27 gene knockout as a novel vaccine candidate: A study on safety, protective immunity and efficacy against canine leishmaniasis caused by Leishmania infantum
S. Elikaee, Z. Zarei, A. Khamesipour, et al.Acta Tropica 225 106153 (2022)
https://doi.org/10.1016/j.actatropica.2021.106153
Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis
Patrícia A.F. Ribeiro, Danniele L. Vale, Daniel S. Dias, et al.Cytokine 129 155031 (2020)
https://doi.org/10.1016/j.cyto.2020.155031
Adjuvants for swine vaccines: Mechanisms of actions and adjuvant effects
Wasin CharerntantanakulVaccine 38 (43) 6659 (2020)
https://doi.org/10.1016/j.vaccine.2020.08.054
Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection
Patrícia A.F. Ribeiro, Daniel S. Dias, Daniela P. Lage, et al.Molecular Immunology 106 108 (2019)
https://doi.org/10.1016/j.molimm.2018.12.025
Visceral leishmaniasis: An overview of vaccine adjuvants and their applications
Sneha Ratnapriya, Keerti, Amogh A. Sahasrabuddhe and Anuradha DubeVaccine 37 (27) 3505 (2019)
https://doi.org/10.1016/j.vaccine.2019.04.092
The potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte response
Manas Ranjan Dikhit, Sushmita Das, Vijaya Mahantesh, et al.Scientific Reports 8 (1) (2018)
https://doi.org/10.1038/s41598-018-32040-x
Therapeutic vaccine of killed Leishmania amazonensis plus saponin reduced parasite burden in dogs naturally infected with Leishmania infantum
Kelvinson Fernandes Viana, Giulia Lacerda, Natália Soares Teixeira, et al.Veterinary Parasitology 254 98 (2018)
https://doi.org/10.1016/j.vetpar.2018.03.010
Detect the presence of LeIF gene in the Leishmania tropica genome and sequence it
Razan Abbara and Mohammad MaaroufMeta Gene 17 28 (2018)
https://doi.org/10.1016/j.mgene.2018.04.003
Immunogenicity and efficacy of a bivalent DNA vaccine containing LeIF and TSA genes against murine cutaneous leishmaniasis
Nahid Maspi, Fatemeh Ghaffarifar, Zohreh Sharifi, Abdolhossein Dalimi and Mohammad Saaid DayerAPMIS 125 (3) 249 (2017)
https://doi.org/10.1111/apm.12651
Immunogenicity in dogs and protection against visceral leishmaniasis induced by a 14kDa Leishmania infantum recombinant polypeptide
Claudia Abeijon, Nada Daifalla, Greice Krautz-Peterson, et al.Trials in Vaccinology 5 1 (2016)
https://doi.org/10.1016/j.trivac.2015.11.001
Identification of Immunoreactive Leishmania infantum Protein Antigens to Asymptomatic Dog Sera through Combined Immunoproteomics and Bioinformatics Analysis
Maria Agallou, Evita Athanasiou, Martina Samiotaki, et al.PLOS ONE 11 (2) e0149894 (2016)
https://doi.org/10.1371/journal.pone.0149894
Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum
Jacqueline Araújo Fiuza, Sreenivas Gannavaram, Helton da Costa Santiago, et al.Vaccine 33 (2) 280 (2015)
https://doi.org/10.1016/j.vaccine.2014.11.039
Immunological comparison of DNA vaccination using two delivery systems against canine leishmaniasis
Mehdi Shahbazi, Farnaz Zahedifard, Noushin Saljoughian, et al.Veterinary Parasitology 212 (3-4) 130 (2015)
https://doi.org/10.1016/j.vetpar.2015.07.005
Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral leishmaniasis
Pranati Das, Ajay Amit, Shubhankar Kumar Singh, et al.Parasitology International 64 (1) 18 (2015)
https://doi.org/10.1016/j.parint.2014.08.004
Evaluation of the immunogenicity and protective efficacy of Killed Leishmania donovani antigen along with different adjuvants against experimental visceral leishmaniasis
Ankita Thakur, Harpreet Kaur and Sukhbir KaurMedical Microbiology and Immunology 204 (4) 539 (2015)
https://doi.org/10.1007/s00430-014-0367-9
Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis
Mehdi Shahbazi, Farnaz Zahedifard, Tahereh Taheri, et al.PLOS ONE 10 (7) e0132794 (2015)
https://doi.org/10.1371/journal.pone.0132794
Identifying vaccine targets for anti-leishmanial vaccine development
Shyam Sundar and Bhawana SinghExpert Review of Vaccines 13 (4) 489 (2014)
https://doi.org/10.1586/14760584.2014.894467
Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins
Maria Agallou, Evita Athanasiou, Olga Koutsoni, Eleni Dotsika and Evdokia KaragouniFrontiers in Immunology 5 (2014)
https://doi.org/10.3389/fimmu.2014.00268
LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4+ and CD8+) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis
Rodrigo Dian de Oliveira Aguiar-Soares, Bruno Mendes Roatt, Henrique Gama Ker, et al.Parasites & Vectors 7 (1) (2014)
https://doi.org/10.1186/1756-3305-7-61
Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends
Ali Badiee, Vahid Heravi Shargh, Ali Khamesipour and Mahmoud Reza JaafariVaccine 31 (5) 735 (2013)
https://doi.org/10.1016/j.vaccine.2012.11.068
Risk Factors for Seroconversion by Leishmania infantum in a Cohort of Dogs from an Endemic Area of Brazil
Wendel Coura-Vital, Alexandre Barbosa Reis, Maria Arlene Fausto, et al.PLoS ONE 8 (8) e71833 (2013)
https://doi.org/10.1371/journal.pone.0071833
Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs
Jacqueline Araújo Fiuza, Helton da Costa Santiago, Angamuthu Selvapandiyan, et al.Vaccine 31 (14) 1785 (2013)
https://doi.org/10.1016/j.vaccine.2013.01.048
Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development
Tahereh Taheri and Sima RafatiClinical Investigation 3 (11) 1023 (2013)
https://doi.org/10.4155/cli.13.99
Performance of LBSap Vaccine after Intradermal Challenge with L. infantum and Saliva of Lu. longipalpis: Immunogenicity and Parasitological Evaluation
Bruno Mendes Roatt, Rodrigo Dian de Oliveira Aguiar-Soares, Juliana Vitoriano-Souza, et al.PLoS ONE 7 (11) e49780 (2012)
https://doi.org/10.1371/journal.pone.0049780
Leishmaniasis: Vaccine candidates and perspectives
Bhawana Singh and Shyam SundarVaccine 30 (26) 3834 (2012)
https://doi.org/10.1016/j.vaccine.2012.03.068
Identification of Leishmania infantum chagasi proteins in urine of patients with visceral leishmaniasis: a promising antigen discovery approach of vaccine candidates
S. S. KASHINO, C. ABEIJON, L. QIN, K. A. KANUNFRE, F. S. KUBRUSLY, F. O. SILVA, D. L. COSTA, D. CAMPOS, C. H. N. COSTA, I. RAW and A. CAMPOS‐NETOParasite Immunology 34 (7) 360 (2012)
https://doi.org/10.1111/j.1365-3024.2012.01365.x
Efficacy of Leishmania donovani ribosomal P1 gene as DNA vaccine in experimental visceral leishmaniasis
Shet Masih, Sunil K. Arora and Rakesh K. VasishtaExperimental Parasitology 129 (1) 55 (2011)
https://doi.org/10.1016/j.exppara.2011.05.014
Vaccine candidates for leishmaniasis: A review
Rajeev Nagill and Sukhbir KaurInternational Immunopharmacology 11 (10) 1464 (2011)
https://doi.org/10.1016/j.intimp.2011.05.008
An experimental protocol for the establishment of dogs with long-term cellular immune reactions to Leishmania antigens
Márcia Cristina Aquino Teixeira, Geraldo Gileno de Sá Oliveira, Patrícia Oliveira Meira Santos, et al.Memórias do Instituto Oswaldo Cruz 106 (2) 182 (2011)
https://doi.org/10.1590/S0074-02762011000200011
Methods of Control of theLeishmania infantumDog Reservoir: State of the Art
Michele Podaliri Vulpiani, Luigi Iannetti, Daniela Paganico, Filomena Iannino and Nicola FerriVeterinary Medicine International 2011 1 (2011)
https://doi.org/10.4061/2011/215964
Comparison between three adjuvants for a vaccine against canine leishmaniasis: In vitro evaluation of macrophage killing ability
T. Trotta, A. Fasanella, D. Scaltrito, et al.Comparative Immunology, Microbiology and Infectious Diseases 33 (2) 175 (2010)
https://doi.org/10.1016/j.cimid.2009.12.003
Immunotherapy with the saponin enriched-Leishmune® vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis
G.P. Borja-Cabrera, F.N. Santos, F.B. Santos, et al.Vaccine 28 (3) 597 (2010)
https://doi.org/10.1016/j.vaccine.2009.09.071
Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis
Alexandre B. Reis, Rodolfo C. Giunchetti, Eugenia Carrillo, Olindo A. Martins-Filho and Javier MorenoTrends in Parasitology 26 (7) 341 (2010)
https://doi.org/10.1016/j.pt.2010.04.005
Humoral and In Vivo Cellular Immunity against the Raw Insect-Derived Recombinant Leishmania infantum Antigens KMPII, TRYP, LACK, and papLe22 in Dogs from an Endemic Area
Felicitat Todolí, José M. Escribano, Rafael de Juan, et al.The American Journal of Tropical Medicine and Hygiene 83 (6) 1287 (2010)
https://doi.org/10.4269/ajtmh.2010.09-0784
T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune®
Márcio Sobreira Silva Araújo, Renata Aline de Andrade, Renato Sathler-Avelar, et al.Vaccine 27 (7) 1008 (2009)
https://doi.org/10.1016/j.vaccine.2008.11.104
Optimized subunit vaccine protects against experimental leishmaniasis
Sylvie Bertholet, Yasuyuki Goto, Lauren Carter, et al.Vaccine 27 (50) 7036 (2009)
https://doi.org/10.1016/j.vaccine.2009.09.066
Adjuvants for porcine reproductive and respiratory syndrome virus vaccines
Wasin CharerntantanakulVeterinary Immunology and Immunopathology 129 (1-2) 1 (2009)
https://doi.org/10.1016/j.vetimm.2008.12.018
Seroreactivity against raw insect-derived recombinant KMPII, TRYP, and LACK Leishmania infantum proteins in infected dogs
Felicitat Todolí, Mariano Pérez-Filgueira, Inmaculada Galindo, et al.Veterinary Parasitology 164 (2-4) 154 (2009)
https://doi.org/10.1016/j.vetpar.2009.05.032
Immunopathology of natural infection with Trypanosoma cruzi in dogs
Julio Vladimir Cruz-Chan, Manuel Bolio-González, Rafael Colín-Flores, et al.Veterinary Parasitology 162 (1-2) 151 (2009)
https://doi.org/10.1016/j.vetpar.2009.02.024
A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis
Connor Carson, Maria Antoniou, Maria Begoña Ruiz-Argüello, et al.Vaccine 27 (7) 1080 (2009)
https://doi.org/10.1016/j.vaccine.2008.11.094
Searching Genes Encoding Leishmania Antigens for Diagnosis and Protection
Manuel Soto, Laura Ramírez, Miguel A. Pineda, et al.Scholarly Research Exchange 2009 1 (2009)
https://doi.org/10.3814/2009/173039
The Chimerical Multi-Component Q protein from Leishmania in the absence of adjuvant protects dogs against an experimental Leishmania infantum infection
J. Carcelén, V. Iniesta, J. Fernández-Cotrina, et al.Vaccine 27 (43) 5964 (2009)
https://doi.org/10.1016/j.vaccine.2009.07.069
IgG subclass profile of serum antibodies to Leishmania chagasi in naturally infected and vaccinated dogs
Trícia M.F.S. Oliveira, Tiago W.P. Mineo, Melina Bason, Michael J. Day and Rosangela Z. MachadoVeterinary Parasitology 162 (1-2) 16 (2009)
https://doi.org/10.1016/j.vetpar.2009.02.018
Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era
Eric DumonteilInfection, Genetics and Evolution 9 (6) 1075 (2009)
https://doi.org/10.1016/j.meegid.2009.02.009
Cutaneous leishmaniasis: progress towards a vaccine
Pascal Launois, Fabienne Tacchini-Cottier and Marie-Paul KienyExpert Review of Vaccines 7 (8) 1277 (2008)
https://doi.org/10.1586/14760584.7.8.1277
Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime®) and the recombinant Leish-110f®+MPL-SE® vaccine to treat canine visceral leishmaniasis
Jorge Miret, Evaldo Nascimento, Weverton Sampaio, et al.Vaccine 26 (12) 1585 (2008)
https://doi.org/10.1016/j.vaccine.2008.01.026
Immunogenicity assay of the Leishmune® vaccine against canine visceral leishmaniasis in Brazil
G.P. Borja-Cabrera, F.N. Santos, F.S. Bauer, et al.Vaccine 26 (39) 4991 (2008)
https://doi.org/10.1016/j.vaccine.2008.07.029
FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine
Clarisa B Palatnik-de-Sousa, André de Figueiredo Barbosa, Sandra Maria Oliveira, et al.Expert Review of Vaccines 7 (6) 833 (2008)
https://doi.org/10.1586/14760584.7.6.833
Antigenicity of a whole parasite vaccine as promising candidate against canine leishmaniasis
Rodolfo Cordeiro Giunchetti, Alexandre Barbosa Reis, Denise da Silveira-Lemos, et al.Research in Veterinary Science 85 (1) 106 (2008)
https://doi.org/10.1016/j.rvsc.2007.09.008
Vaccines for leishmaniasis in the fore coming 25 years
Clarisa B. Palatnik-de-SousaVaccine 26 (14) 1709 (2008)
https://doi.org/10.1016/j.vaccine.2008.01.023
Visceral leishmaniasis in large Brazilian cities: challenges for control
Claudia Di Lorenzo Oliveira, Maria Helena Franco Morais and George Luiz Lins Machado-CoelhoCadernos de Saúde Pública 24 (12) 2953 (2008)
https://doi.org/10.1590/S0102-311X2008001200026
Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis
Eugenia Carrillo, Martín Crusat, Javier Nieto, et al.Vaccine 26 (15) 1902 (2008)
https://doi.org/10.1016/j.vaccine.2008.01.042
Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge
Alhelí Rodríguez-Cortés, Ana Ojeda, Laura López-Fuertes, et al.Vaccine 25 (46) 7962 (2007)
https://doi.org/10.1016/j.vaccine.2007.08.023
Interleukin-6 has differential influence on the ability of adjuvant formulations to potentiate antibody reponses to a Plasmodium falciparum blood-stage vaccine
George Hui and Caryn HashimotoVaccine 25 (36) 6598 (2007)
https://doi.org/10.1016/j.vaccine.2007.06.057
Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs
Rodolfo Cordeiro Giunchetti, Rodrigo Corrêa-Oliveira, Olindo Assis Martins-Filho, et al.Vaccine 25 (44) 7674 (2007)
https://doi.org/10.1016/j.vaccine.2007.08.009
Leishmania major: Immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes
Ali Badiee, Mahmoud R. Jaafari and Ali KhamesipourExperimental Parasitology 115 (2) 127 (2007)
https://doi.org/10.1016/j.exppara.2006.07.002
Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis
J. Moreno, J. Nieto, S. Masina, et al.Vaccine 25 (29) 5290 (2007)
https://doi.org/10.1016/j.vaccine.2007.05.010
Leishmaniavaccines: progress and problems
L. KEDZIERSKI, Y. ZHU and E. HANDMANParasitology 133 (S2) S87 (2006)
https://doi.org/10.1017/S0031182006001831
Immunology of canine leishmaniasis
C. L. BARBIÉRIParasite Immunology 28 (7) 329 (2006)
https://doi.org/10.1111/j.1365-3024.2006.00840.x
Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment
M. T. M. RobertsBritish Medical Bulletin 75-76 (1) 115 (2005)
https://doi.org/10.1093/bmb/ldl003